| organlaallon for sickle cell Anaanlla R Salanos Sheet |
saaara | b loac*R) sa | ndwsll | |||
|---|---|---|---|---|---|---|
| Aa at 31 Marsh 2022 | ||||||
| Nots | Unraslrlolad | Rsafrlatad | 2022 | 2021 | ||
| funds | funda | Total funds | Total funds | |||
| 8 | e | 8 | 8 | |||
| FIXED ASSETS | ||||||
| Tangible aassla | 13,478 | 118,888 | IX,348 | 132,484 | ||
| CURRENT ASSETS | ||||||
| Debtors | ||||||
| Cash at bank and lnhand | 112890 | 112890 | 114498 | |||
| CREDITORS | 112,890 | 112,890 | 114,498 | |||
| Amounts falling dus within ons year |
9 | 1,879 | 1,879 | 2,079 | ||
| NET CURRENT ASSETS | 111,011 | 111,011 | 112.419 | |||
| TOTAL ASSETSLESSCURRENT | 124,489 | 118,888 | 241,357 | 244,883 | ||
| LIABILITIES | ||||||
| CREDITORS | ||||||
| Amounts falling due mors than one year |
||||||
| NET ASSETS | 124,489 | 116,868 | 241,357 | |||
| FUNDS | ||||||
| Unrestricted funds |
124,489 | 124,547 | ||||
| Restricted fund |
116,868 | 120,336 | ||||
| ' | TOTAL FUNDS | 241,357 | 244,883 |
| Note | Unrestricted | Restricted | 2022 | 2021 | |||
|---|---|---|---|---|---|---|---|
| funds | funds | Total funds | Total funds | ||||
| E | E | E | E | ||||
| INCOME FROM: | |||||||
| Donations snd legacies |
3,809 | 3,809 | 4,727 | ||||
| Charitable activities |
65,394 | 65,394 | 79,183 | ||||
| Investment income |
5 | 5 | 8 | ||||
| Other income | |||||||
| Total Income | 69,208 | 69,208 | 83,918 | ||||
| EXPENDITURE ON: | |||||||
| Charitable activities |
67,766 | 3,468 | 71,234 | 52,557 | |||
| Other resources expended | |||||||
| Governance costs |
1,500 | 1,500 | 1,500 | ||||
| Total resources expended | 69,266 | 3,468 | 72,734 | 54,057 | |||
| NET INCOMING RESOURCES | BEFORE | (58) | (3,468) | (3,526) | 29,861 | ||
| TRANSFERS | |||||||
| Gross transfers between |
funds | ||||||
| (58) | (3,468) | (3,526) | 29,861 | ||||
| RECONCILIATION | OF FUNDS | ||||||
| ;,Total funds brought | forward | 124,547 | 120,336 | 244,883 | 215,022 | ||
| Movement between |
funds | ||||||
| TOTAL FUNDS CARRIED | FORWARD | 124,489 | 116,868 | 241,357 | 244,883 |
| Organlsatlon for Sickle Cell Anaemla |
Organlsatlon for Sickle Cell Anaemla |
Research (OSCAR) Sandwell | ||
|---|---|---|---|---|
| Notes to the Financial Statements | ||||
| For the year ended 31 INarch | 2022 (continued) | |||
| 2.1,Donations and legacies |
2022 E |
2021 E |
||
| Donations and gifts |
3,809 | 4,727 | ||
| Legacies receivable | ||||
| 3,909 | 4,727 | |||
| 2.2.Charitable activities |
2022 E |
2021 E |
||
| Perfonnance related grants African Health Policy Network (COVID Furlough income (COVID related Covid Survey project Engaging Community Project Grants received Other charitable activities |
related) | 48,491 4,297 2,000 500 9,904 202 |
58,613 10,000 10,570 |
|
| 65.394 | 79.193 | |||
| Analysis by funds Unrestricted funds |
69,203 | |||
| Restricted funds |
69,203 | |||
| Forthe year ended 31March | 2021 | |||
| Unrestricted funds |
83,910 | |||
| Restricted funds |
83,910 | |||
| 3.Investment income |
2022 | 2021 | ||
| E | E | |||
| Interest receivable | ||||
| 4.Charitable activities expenditure |
2022 | 2021 | ||
| E | E | |||
| Staff costs Depreciation and impaiment Other charitable expenditure |
54,511 5,443 1,396 61,350 |
36,948 4,335 1,090 42,373 |
||
| Share of support costs (see note 5) share of governance costs (see note |
5) | 9.884 1,500 72.734 |
10,184 1,500 64 p57 |
|
| Analysis by funds Unrestricted funds Restricted funds |
69,266 3,468 72.734 |
50,589 3,468 54 p57 |
||
| Forthe year ended 31March 2020 Unrestricted funds |
50,589 | |||
| Restricted funds |
3,468 | |||
| 54.057 |
| S.Support c | osta | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Support | costa | Governance | Total | Total | |||||
| costs | 2022 | 2021 | |||||||
| E | E | E | E | ||||||
| Support Governance |
9884 | 1500 | 9,884 1,500 |
10,184 1,500 |
|||||
| 9,884 | 1,500 | 11,384 | 11,684 | ||||||
| Analyae between: |
|||||||||
| Charitable activities Non-charitable activities |
9,884 | 1,500 | 11,384 | 11,684 | |||||
| 9,884 | 1,500 | 11,384 | 11,684 | ||||||
| 8.Employment | |||||||||
| Number ofempolyees | |||||||||
| The average | monthly | number | ofemployees | during | the | year was: | 2022 | 2021 | |
| Number | Number | ||||||||
| General staff | |||||||||
| Employment | costs | ||||||||
| 2022 | 2021 | ||||||||
| E | E | ||||||||
| Wages and salaries | 54,511 | 36,948 | |||||||
| 54,511 | 36.948 |
| Land snd | Property | Computer | Fixtures and | Office | ||
|---|---|---|---|---|---|---|
| Buildings | Improvements | Squipmsnt | fittings | Equipment | Total | |
| Cost | 6 | 8 | 6 | |||
| 01/04/2021 | 218,737 | 4,187 | 7,566 | 43,349 | 271,839 | |
| Additions | 3,326 | 3,326 | ||||
| Olsposais | ||||||
| 31/03/2022 | 216,737 | 4,187 | 3,326 | 7,566 | 43,349 | 275,166 |
| Oepreciabon | ||||||
| 01/04/2021 | 91,898 | 1,101 | 3,028 | 43,349 | 139,376 | |
| Disposals | ||||||
| Charge for the year |
3,468 | 110 | 1,109 | 757 | 5,444 | |
| 31/03/2022 | 95,366 | 1,211 | 1,109 | 3,785 | 43,349 | 144,820 |
| Net book value | ||||||
| 31/03/2022 | 121,371 | 2,976 | 2,217 | 3,782 | ||
| 31/03/2021— | 124,839 | 3,086 | 4,539 | 132,464 | ||
| 8.Oebtors | 2022 | |||||
| 6 |
| Notes to the Financial Statements | Notes to the Financial Statements | Notes to the Financial Statements | ||||
|---|---|---|---|---|---|---|
| For the year ended 31 March 2022 (continued) | ||||||
| 10. Movement in funds |
Balance at 1 April 2021 |
Incoming Resources f |
Resources Expended |
Balance at 31 ' March 2022 f |
||
| Restricted funds NLCB Property Grant |
120,336 120,336 |
(3,468) 3,468 |
116,868 116,868 |
|||
| Unrestricted funds Net incoming/outgoing resources |
124,547 | 69,208 | (69,266) | 124,489 | ||
| 124,547 | 69,208 | 69,266 | 124,489 | |||
| TOTAL FUNDS | 244,883 | 69,208 | (72,734) | 241,357 | ||
| 11.Analysis of net assets between Fund balalces at 31 March 2022 are |
funds | Unrestricted fundsf |
Restricted fundsf |
Totalf | ||
| represented by: Tangible fixed assets Current assets(liabilities) |
13,478 111,011 |
116,868 | 130,346 111,011 |
|||
| 124,489 | 116,868 | 241,357 |